emodin has been researched along with concanavalin a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, F; Chen, Z; He, J; Liu, Y; Wang, J; Wu, S; Xue, J; Zheng, M; Zhu, H | 1 |
1 other study(ies) available for emodin and concanavalin a
Article | Year |
---|---|
Emodin protects against concanavalin A-induced hepatitis in mice through inhibiting activation of the p38 MAPK-NF-κB signaling pathway.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; CD11b Antigen; CD4-Positive T-Lymphocytes; Cell Line; Chemokines; Concanavalin A; Cytokines; Emodin; Hepatitis; Liver; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protective Agents; Signal Transduction | 2015 |